Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    21270442 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study of CEP-701 (Lestaurtinib) in Patients With Acute Myeloid Leukemia (AML)
Condition: Acute Myeloid Leukemia
Interventions: Drug: CEP-701;   Drug: high-dose cytarabine;   Drug: Mitozantrone, Etoposide, Cytarabine (combination Chemotherapy)

Study has passed its completion date and status has not been verified in more than two years.